Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.19USD
−105.79 MUSD
327.84 M
About CARSGEN THERAPEUTICS HLDGS LTD
Sector
CEO
Zong Hai Li
Headquarters
Shanghai
Website
Employees (FY)
516
Founded
2018
FIGI
BBG015HYFPR3
CARsgen Therapeutics Holdings Ltd. is a clinical-stage biopharmaceutical company, which engages in discovering, researching, and developing cell therapies. The firm focuses on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors. The company was founded by Zong Hai Li and Hua Mao Wang on February 9, 2018, and is headquartered in Shanghai, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of CRTHF is 1.67 USD — it has decreased by 10.22% in the past 24 hours. Watch CARSGEN THERAPEUTICS HLDGS LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange CARSGEN THERAPEUTICS HLDGS LTD. stocks are traded under the ticker CRTHF.
We've gathered analysts' opinions on CARSGEN THERAPEUTICS HLDGS LTD. future price: according to them, CRTHF price has a max estimate of 1.10 USD and a min estimate of 0.74 USD. Watch CRTHF chart and read a more detailed CARSGEN THERAPEUTICS HLDGS LTD. stock forecast: see what analysts think of CARSGEN THERAPEUTICS HLDGS LTD. and suggest that you do with its stocks.
CRTHF reached its all-time high on Sep 22, 2017 with the price of 7.29 USD, and its all-time low was 1.67 USD and was reached on Dec 4, 2023. View more price dynamics on CRTHF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
CRTHF stock is 11.38% volatile and has beta coefficient of 1.60. Track CARSGEN THERAPEUTICS HLDGS LTD. stock price on the chart and check out the list of the most volatile stocks — is CARSGEN THERAPEUTICS HLDGS LTD. there?
Today CARSGEN THERAPEUTICS HLDGS LTD. has the market capitalization of 483.11 M, it has decreased by 17.84% over the last week.
Yes, you can track CARSGEN THERAPEUTICS HLDGS LTD. financials in yearly and quarterly reports right on TradingView.
CARSGEN THERAPEUTICS HLDGS LTD. is going to release the next earnings report on Aug 20, 2024. Keep track of upcoming events with our Earnings Calendar.
CRTHF earnings for the last quarter are −0.09 USD per share, whereas the estimation was −0.12 USD resulting in a 29.55% surprise. The estimated earnings for the next quarter are −0.04 USD per share. See more details about CARSGEN THERAPEUTICS HLDGS LTD. earnings.
CARSGEN THERAPEUTICS HLDGS LTD. revenue for the last quarter amounts to 0 USD despite the estimated figure of 0 USD. In the next quarter revenue is expected to reach 33.98 M USD.
CRTHF net income for the last quarter is −47.49 M USD, while the quarter before that showed −58.36 M USD of net income which accounts for 18.63% change. Track more CARSGEN THERAPEUTICS HLDGS LTD. financial stats to get the full picture.
No, CRTHF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 18, 2024, the company has 516.00 employees. See our rating of the largest employees — is CARSGEN THERAPEUTICS HLDGS LTD. on this list?
Like other stocks, CRTHF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CARSGEN THERAPEUTICS HLDGS LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CARSGEN THERAPEUTICS HLDGS LTD. technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CARSGEN THERAPEUTICS HLDGS LTD. stock shows the buy signal. See more of CARSGEN THERAPEUTICS HLDGS LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.